What other stocks do shareholders of Takeda Pharmaceutical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Takeda Pharmaceutical investors own include Pure Gold Mining (PGM) , Valhi (VHI) and Fission Uranium (FCUUF) .

How do I buy shares of Takeda Pharmaceutical?

Shares of TAK stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor , Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. Compare Top Brokerages Here .

CVE:TAK

Takeda Pharmaceutical (TAK) Stock Price, News & Analysis

→ Forget Nvidia, buy this A.I. Stock Now (From InvestorPlace) (Ad)

Free TAK Stock Alerts

Compare

Today's Range: N/A
50-Day Range: N/A
52-Week Range: N/A

Volume: N/A
Average Volume: 143,897 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Takeda Pharmaceutical alerts:

Ad Gold Safe Exchange

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

About Takeda Pharmaceutical Stock (CVE:TAK)

The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company, with partial American and British roots. It is the largest pharmaceutical company in Asia and one of the top 20 largest pharmaceutical companies in the world by revenue.

Ad Gold Safe Exchange

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

TAK Stock News Headlines

April 15, 2024 | seekingalpha.com

Jazz Pharmaceuticals: Targeting The Low-Hanging Fruit In Oncology Might Pay Off

April 12, 2024 | bizjournals.com

Viewpoint: To stay on top, Boston must lead pharma’s transformation

April 17, 2024 | Paradigm Press (Ad)

Bitcoin Rockets To Record High But Buy THIS Instead

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

April 11, 2024 | benzinga.com

Assessing Johnson & Johnson's Performance Against Competitors In Pharmaceuticals Industry

April 3, 2024 | stockhouse.com

Ligand Pharmaceuticals Announces Launch of Pelthos Therapeutics to Accelerate Commercialization of ZELSUVMI(TM)

March 30, 2024 | msn.com

This could be the worst year yet for dengue in the Americas

March 27, 2024 | finance.yahoo.com

Ephicacy Bolsters Leadership Team with Four New Hires

March 27, 2024 | finanznachrichten.de

Takeda Pharmaceuticals: Empathy in Action: Takeda's Global Initiative Brings IBD Challenges to the Forefront in the UAE

April 17, 2024 | Paradigm Press (Ad)

Bitcoin Rockets To Record High But Buy THIS Instead

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

March 20, 2024 | markets.businessinsider.com

Scilex, Takeda Settle Paragraph IV Patent Infringement Lawsuit - Quick Facts

March 13, 2024 | markets.businessinsider.com

Takeda: Mezagitamab Phase 2 Trial Shows Positive Results In Primary Immune Thrombocytopenia

March 13, 2024 | msn.com

University Of Strathclyde Invites Applications For MSc Advanced Pharmaceutical Manufacturing Course Starting September 2024

February 28, 2024 | finance.yahoo.com

Takeda Pharmaceutical Co Ltd (TKD.HM)

February 28, 2024 | msn.com

Takeda and Biological E partner to boost dengue vaccine production in India

February 27, 2024 | finance.yahoo.com

Cholera Vaccines Market to Reach USD 167.3 Million by 2030, Fueled by a CAGR of 9.0% from 2030 | MarketDigits

February 27, 2024 | sg.finance.yahoo.com

Takeda Accelerates Access to its Dengue Vaccine Through 'Make in India' Manufacturing Partnership with Biological E.

February 27, 2024 | markets.businessinsider.com

Takeda Signs Manufacturing Partnership With India's Biological E. For Dengue Vaccine QDENGA

February 27, 2024 | news.yahoo.com

Japan's Takeda partners with India's Biological E. to boost dengue vaccine production

February 25, 2024 | finance.yahoo.com

Nasdaq DM Asia Health Care Larg (^NQDMASIA20LMGBP)

February 23, 2024 | forbes.com

A Decade Of Innovation: How This CEO Transformed A Global Pharma Giant

February 20, 2024 | investing.com

Takeda Pharmaceutical Co Ltd ADR (TAK)

February 16, 2024 | finance.yahoo.com

Ligand Pharmaceuticals Expands Senior Leadership Team with Two Key Hires

February 12, 2024 | msn.com

FDA Approves Takeda's Eohilia As First Oral Treatment For Inflammed Esophagus

February 12, 2024 | markets.businessinsider.com

Centessa Pharmaceuticals: Buy Rating Backed by Strong Pipeline and Positive Drug Data

February 12, 2024 | markets.businessinsider.com

Takeda Says FDA Approves EOHILIA To Treat Eosinophilic Esophagitis

February 12, 2024 | reuters.com

Takeda's treatment becomes first oral therapy for esophageal condition in US

January 31, 2024 | msn.com

EU okays Takeda's Hyqvia co-formulated with Halozyme's Enhanze

See More Headlines

Receive TAK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Takeda Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: CVE
Sector: Manufacturing
Industry: Medicinal & Botanical Manufacturing
Sub-Industry: N/A
Current Symbol: CVE:TAK
CUSIP: N/A
CIK: N/A
Web: www.takugold.com
Phone: +1-604-6420115
Fax: N/A
Employees: 2,021
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Key Executives

Gilles Dessureau
Interim President
Gregory Donald Hayes
Interim Chief Financial Officer, Corporate Secretary
Peter Bures
Director
Dennis Gordon Fentie
Director
Janet Lee-Sheriff
Director
Lori Walton
Director
C.F. Wasser III
Director

Key Competitors

View All Competitors

TAK Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Takeda Pharmaceutical own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Takeda Pharmaceutical investors own include Pure Gold Mining (PGM), Valhi (VHI) and Fission Uranium (FCUUF).
How do I buy shares of Takeda Pharmaceutical?: Shares of TAK stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (CVE:TAK) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Takeda Pharmaceutical (TAK) Stock Price, News & Analysis

About Takeda Pharmaceutical Stock (CVE:TAK)

TAK Stock News Headlines

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

TAK Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info